<SEC-DOCUMENT>0001610717-26-000223.txt : 20260615
<SEC-HEADER>0001610717-26-000223.hdr.sgml : 20260615
<ACCEPTANCE-DATETIME>20260615171229
ACCESSION NUMBER:		0001610717-26-000223
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260611
FILED AS OF DATE:		20260615
DATE AS OF CHANGE:		20260615

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Moore David Scott
		CENTRAL INDEX KEY:			0002088466
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37719
		FILM NUMBER:		261091891

	MAIL ADDRESS:	
		STREET 1:		C/O CORVUS PHARMACEUTICALS, INC.
		STREET 2:		901 GATEWAY BOULEVARD, THIRD FLOOR
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Corvus Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001626971
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				464670809
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		901 GATEWAY BLVD, THIRD FLOOR
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 900-4520

	MAIL ADDRESS:	
		STREET 1:		901 GATEWAY BLVD, THIRD FLOOR
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
</DOCUMENT>
</SUBMISSION>